Page last updated: 2024-08-24

chromic phosphate and Cancer of Ovary

chromic phosphate has been researched along with Cancer of Ovary in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	18 (48.65)	18.7374
1990's	15 (40.54)	18.2507
2000's	4 (10.81)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balink, H; De Klerk, JM; Sijmons, EA; Zonnenberg, BA	1
Alvarez, RD; Benda, JA; Bundy, BN; Clarke-Pearson, DL; Long, HJ; Stehman, FB; Varia, MA	1
Alberts, DS; Brady, MF; Hurteau, J; Lentz, SS; Long, HJ; Mayer, AR; Nieberg, RK; Young, RC	1
Bakshi, S; Barlow, JJ; Bender, MA; Lele, SB; Parthasarathy, KL; Piver, MS	1
Bakri, YN; Given, FT	1
Carlson, JA; Jose, B; Osborne, RP; Sharma, SC	2
Kirchner, AB; Powell, JL	1
Creasman, WT; Currie, JL; Harris, CC; Sullivan, DC; Wilkinson, RH	1
Adelstein, SJ; Bloomer, WD; Gordon, PR; McLaughlin, WH; Neirinckx, RD; Ruth, TJ; Wolf, AP	1
Backx, C; Cash, SA; Durand, RE; Leichner, PK	1
Blessing, J; Creasman, WT; Disaia, PJ; Johnston, W; Weed, JC; Wilkinson, RH	1
McGowan, L	2
Abdel-Dayem, H; Collier, BD; Hamilton, K; Ozker, K; Pattillo, RA; Ruckert, AC; Wilson, C	1
Ball, H; Bankoff, M; Bornstein, L; Goodman, A; Smith, DM	1
Eggli, DF; Tulchinsky, M	1
DeVictoria, CL; Gaudette, DE; Goldberg, GL; Milstein, DM; Runowicz, CD; Smith, HO	1
Bolis, G; Bonazzi, C; Chiari, S; Colombo, N; Favalli, G; Mangili, G; Marsoni, S; Pecorelli, S; Presti, M; Torri, V	1
Wilkinson, RH	1
Day, TG; Doering, D; Makhija, S; Spanos, WJ	1
Corn, B; Lanciano, R; Randall, M; Reddy, S	1
Dent, SF; Klaassen, D; Pater, JL; Whitehead, M; Zee, B	1
Cain, JM; Lee, RB; Peters, WA; Smith, MR; Yon, JL	1
Berchuck, A; Clarke-Pearson, DL; Dodge, R; Soper, JT	1
Berchuck, A; Clarke-Pearson, DL; Soper, JT	1
Rubinstein, L; Walton, LA; Yadusky, A	1
Barnhill, D; Doering, D; Park, R; Proctor, J	1
Austin, JM; Hatch, KD; Kim, RY; Partridge, EE; Potter, ME; Shingleton, HM; Soong, SJ	1
Boyes, D; Carmichael, J; Fraser, R; Gerulath, A; Kirk, M; Klaassen, D; Levitt, M; Methot, Y; Shelley, W; Starreveld, A	1
Bakshi, S; Emrich, LJ; Lele, SB; Parthasarathy, KL; Piver, MS	1
Askin, F; Currie, J; Fowler, W; Halle, J; Rosenman, J; Varia, M; Venkatraman, S; Walton, L	1
Burrell, MO; Kirchner, AB; Powell, JL	1
Bandy, LC; Clarke-Pearson, DL; Creasman, WT; Soper, JT; Wilkinson, RH	1
Ehrlich, CE; Hornback, NB; Reddy, S; Stehman, FB; Sutton, GP	1
Flower, MA; Jones, A; McCready, VR; Ott, RJ	1
Boyes, D; Gerulath, A; Klaassen, D; Levitt, M; Miller, A; Shelly, W; Starreveld, A	1

Reviews

3 review(s) available for chromic phosphate and Cancer of Ovary

Article	Year
The management of elderly patients with gynecologic cancer. Current opinion in obstetrics & gynecology, 1995, Volume: 7, Issue:1 Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Chromium Compounds; Combined Modality Therapy; Endometrial Neoplasms; Female; Genital Neoplasms, Female; Humans; Injections, Intraperitoneal; Ovarian Neoplasms; Phosphates; Uterine Cervical Neoplasms	1995
Update on the role of radiotherapy in ovarian cancer. Seminars in oncology, 1998, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chromium Compounds; Combined Modality Therapy; Female; Humans; Injections, Intraperitoneal; Neoplasm Staging; Ovarian Neoplasms; Palliative Care; Phosphates; Phosphorus Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Salvage Therapy; Technetium Tc 99m Sulfur Colloid	1998
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications. International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:5 Topics: Adolescent; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Melphalan; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Radiotherapy	1991

Trials

9 trial(s) available for chromic phosphate and Cancer of Ovary

Article	Year
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome	2003
Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Dec-01, Volume: 21, Issue:23 Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Chromium Compounds; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Survival Rate; Treatment Outcome	2003
Intraperitoneal distribution imaging prior to chromic phosphate (P-32) therapy in ovarian cancer patients. Clinical nuclear medicine, 1994, Volume: 19, Issue:1 Topics: Chromium Compounds; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radionuclide Imaging; Sodium Chloride; Technetium Tc 99m Sulfur Colloid; Tissue Distribution	1994
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Chromium Compounds; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Survival Rate; Treatment Outcome	1995
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG). Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:1 Topics: Antineoplastic Agents, Alkylating; Brachytherapy; Canada; Chromium Compounds; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Melphalan; Neoplasm Staging; Neoplasms, Second Primary; Ovarian Neoplasms; Phosphates; Survival Rate; Time Factors	2000
Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary. Gynecologic oncology, 1992, Volume: 47, Issue:2 Topics: Adult; Aged; Brachytherapy; Carcinoma; Chromium; Chromium Compounds; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Humans; Intestines; Life Tables; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiation Injuries; Reoperation; Survival Analysis	1992
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications. International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:5 Topics: Adolescent; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Melphalan; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Radiotherapy	1991
Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:8 Topics: Chromium; Chromium Compounds; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Melphalan; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Random Allocation	1988
External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: a toxic combination. A National Cancer Institute of Canada Clinical Trials Group Report. International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:10 Topics: Brachytherapy; Chromium; Chromium Compounds; Female; Humans; Melphalan; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes	1985

Other Studies

26 other study(ies) available for chromic phosphate and Cancer of Ovary

Article	Year
Repetitive phosphorus-32 peritoneal instillations in a patient with malignant ascites. Clinical nuclear medicine, 2003, Volume: 28, Issue:7 Topics: Adenocarcinoma, Papillary; Adult; Ascites; Chromium Compounds; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Ovarian Neoplasms; Palliative Care; Paracentesis; Peritoneal Neoplasms; Phosphates; Radiopharmaceuticals; Treatment Outcome	2003
Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma. American journal of obstetrics and gynecology, 1982, Dec-01, Volume: 144, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Laparoscopy; Middle Aged; Ovarian Neoplasms; Phosphates; Prognosis; Prospective Studies	1982
Radioactivity in blood and urine following intraperitoneal instillation of chromic phosphate in patients with and without ascites. American journal of obstetrics and gynecology, 1984, Sep-15, Volume: 150, Issue:2 Topics: Adult; Aged; Ascites; Brachytherapy; Chromium; Chromium Compounds; Female; Humans; Kinetics; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Uterine Neoplasms	1984
Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer. Health physics, 1984, Volume: 47, Issue:3 Topics: Breast Feeding; Chromium; Chromium Compounds; Cystadenocarcinoma; Female; Humans; Infant, Newborn; Milk, Human; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiation Dosage	1984
Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer. American journal of obstetrics and gynecology, 1983, Dec-01, Volume: 147, Issue:7 Topics: Adult; Breast Feeding; Chromium; Chromium Compounds; Cystadenocarcinoma; Female; Humans; Infant, Newborn; Injections, Intraperitoneal; Milk, Human; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Pregnancy; Pregnancy Complications, Neoplastic	1983
Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer. Journal of the Medical Association of Georgia, 1984, Volume: 73, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis	1984
Observations on the intraperitoneal distribution of chromic phosphate (32P) suspension for intraperitoneal therapy. Radiology, 1983, Volume: 146, Issue:2 Topics: Chromium; Chromium Compounds; Female; Humans; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Posture; Radionuclide Imaging; Sulfur; Technetium; Technetium Tc 99m Sulfur Colloid; Time Factors; Tissue Distribution	1983
Astatine-211--tellurium radiocolloid cures experimental malignant ascites. Science (New York, N.Y.), 1981, Apr-17, Volume: 212, Issue:4492 Topics: Alpha Particles; Animals; Ascites; Astatine; Cell Survival; Chromium; Chromium Compounds; Colloids; Female; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radioisotopes; Tellurium; Transplantation, Homologous	1981
Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p. Radiology, 1981, Volume: 141, Issue:1 Topics: Animals; Autoradiography; Carcinoma; Cell Line; Chromium; Chromium Compounds; Cricetinae; Diaphragm; Dose-Response Relationship, Radiation; Female; Injections, Intraperitoneal; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiotherapy Dosage; Rats	1981
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. American journal of obstetrics and gynecology, 1981, Dec-15, Volume: 141, Issue:8 Topics: Adenocarcinoma; Ascitic Fluid; Chromium; Chromium Compounds; Female; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Cervical Neoplasms; Uterine Neoplasms	1981
Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:1 Topics: Adenocarcinoma; Cell Survival; Chromium Compounds; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiotherapy Dosage; Survival Rate; Tumor Cells, Cultured	1995
Chromic phosphate therapy in carcinoma of the ovary. Journal of the American College of Surgeons, 1994, Volume: 179, Issue:4 Topics: Adult; Carcinoma; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Phosphates; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	1994
Adjuvant intraperitoneal chromic phosphate therapy in a woman with early ovarian carcinoma and pelvic infection with resulting catastrophic complications. Clinical nuclear medicine, 1994, Volume: 19, Issue:8 Topics: Adult; Chromium Compounds; Contraindications; Cystadenoma, Mucinous; Female; Humans; Hysterectomy; Instillation, Drug; Ovarian Neoplasms; Pelvic Inflammatory Disease; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiation Injuries; Radiotherapy, Adjuvant	1994
Single-use percutaneous catheters for intraperitoneal P32 therapy. Cancer, 1994, May-15, Volume: 73, Issue:10 Topics: Adult; Aged; Catheterization; Catheterization, Central Venous; Chromium Compounds; Disposable Equipment; Endometrial Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Retrospective Studies	1994
Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4 Topics: Chromium Compounds; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Pleura; Pleural Effusion; Technetium Tc 99m Sulfur Colloid; Time Factors; Tissue Distribution	1996
CA-125 levels after surgical exploration and radioactive chromic phosphate in ovarian cancer patients. Gynecologic oncology, 1996, Volume: 63, Issue:1 Topics: CA-125 Antigen; Chromium Compounds; Female; Humans; Injections, Intraperitoneal; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Postoperative Period; Reoperation; Retrospective Studies	1996
Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging. Obstetrics and gynecology, 1992, Volume: 79, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Chromium; Chromium Compounds; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Survival Analysis	1992
Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging. Cancer, 1991, Aug-15, Volume: 68, Issue:4 Topics: Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Retrospective Studies; Survival Analysis	1991
Bowel perforation associated with intraperitoneal chromic phosphate instillation. Gynecologic oncology, 1990, Volume: 36, Issue:1 Topics: Chromium; Chromium Compounds; Colonic Diseases; Cystadenocarcinoma; Female; Humans; Intestinal Perforation; Middle Aged; Ovarian Neoplasms; Phosphates	1990
Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits. Gynecologic oncology, 1989, Volume: 32, Issue:3 Topics: Chromium; Chromium Compounds; Female; Humans; Instillation, Drug; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes	1989
Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma. American journal of clinical oncology, 1988, Volume: 11, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Chromium; Chromium Compounds; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Time Factors	1988
Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer. Cancer, 1988, Mar-01, Volume: 61, Issue:5 Topics: Carcinoma; Chromium; Chromium Compounds; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Reoperation	1988
Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer. Southern medical journal, 1987, Volume: 80, Issue:12 Topics: Adenocarcinoma; Brachytherapy; Chromium; Chromium Compounds; Cystadenocarcinoma; Endometriosis; Female; Humans; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes	1987
Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging. American journal of obstetrics and gynecology, 1987, Volume: 156, Issue:5 Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Papillary; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Reoperation	1987
Ovarian carcinoma: adjuvant treatment with P-32. Radiology, 1987, Volume: 165, Issue:1 Topics: Brachytherapy; Carcinoma; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Posture; Radiotherapy Dosage	1987
The measurement of radiation doses from P32 chromic phosphate therapy of the peritoneum using SPECT. European journal of nuclear medicine, 1985, Volume: 11, Issue:8 Topics: Chromium; Chromium Compounds; Female; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Phosphates; Phosphorus Radioisotopes; Radiation Dosage; Tomography, Emission-Computed	1985